The Rotterdam criteria is an ever-evolving diagnostic guideline for the diagnosis of polycystic ovarian syndrome (PCOS).1
Because PCOS is a syndrome – meaning, a collection of signs and symptoms often found together – no one set of criteria can be used exclusively for diagnosis. The original 1990 criteria were updated in 2004.
The Rotterdam criteria and diagnosis of PCOS requires two of these three manifestations:
- Irregular or absent ovulation
- Elevated levels of androgenic hormones
- Enlarged ovaries or one ovary containing at least 12 follicles, measuring 2-9mm or have an increased volume of 10ml or more
Symptoms of PCOS that may assist diagnosis include:
- Hyperandrogenism – testing free testosterone levels or free testosterone index
- Polycystic ovaries
- Menstrual irregularities
- Signs of androgen excess
- Obesity
- Insulin resistance
- Elevated blood luteinising hormone (LH) levels
- Increased risk of type II diabetes, cardiovascular disease/events, and endometrial cancer
Symptoms of PCOS include
- Hirsutism (male-type hair growth)
- Menstrual irregularities
- Acne
These criteria were updated by the European Society for Human Reproduction and Embryology (ESHRE), the American Society for Reproductive Medicine (ASRM), and cosponsored by the Rotterdam PCOS consensus workshop group in 2004, published in the January 2004 issue of Fertility and Sterility.2,3
Testing should include metabolic syndrome testing for abdominal obesity (visceral fat), fat levels in the blood, high blood pressure, and glucose testing.
Those who have symptoms but don’t fit the clinical criteria may still have PCOS, however in a ‘mild’ form. Not everyone experiences PCOS the same way, with varying degrees of issues found.
Diagnosis of exclusion – things to rule out
- Cushing’s syndrome
- Androgen-secreting tumours
- Congenital adrenal hyperplasia
- Check follicle-stimulating hormone (FSH) levels and prolactin levels for thyroid conditions
Things to know about PCOS diagnosis
If the ovaries appear normal and there is no sign of hyperandrogenism, further testing is required. Just having polycystic ovaries is not enough, without other clinical signs, to provide a diagnosis of PCOS.
About half of those diagnosed with PCOS have insulin resistance, requiring glucose testing. LH/FSH ratios may be elevated in those with PCOS without recent ovulation, but researchers are not sure why.4,5
Older studies didn’t find an increase in overall deaths, but PCOS does raise cardiometabolic risk, and a recent large cohort found a modest rise in mortality, driven by cardiovascular and cancer deaths.6,7
Frequently asked questions
How is PCOS diagnosed?
PCOS is diagnosed using the Rotterdam criteria: you need two of three features – irregular or absent ovulation, signs of high androgens, and polycystic ovaries on ultrasound (at least 12 follicles measuring 2-9 mm, or an ovary volume of 10 ml or more). Other conditions have to be ruled out first.
Can you have PCOS with normal-looking ovaries?
Yes. Polycystic ovaries are only one of the three criteria, so you can be diagnosed on irregular ovulation and high androgens without them. Equally, simply having polycystic ovaries without other signs is not enough for a diagnosis.
What needs to be ruled out before diagnosing PCOS?
Conditions that mimic PCOS are excluded first, including Cushing’s syndrome, androgen-secreting tumours, congenital adrenal hyperplasia, and thyroid problems (checked with FSH and prolactin levels).
This article is general information and not a substitute for personalised medical advice. If you think you may have PCOS, please see an experienced practitioner.
- Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism. 2023;108(10):2447–2469.
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility. 2004;81(1):19–25.
- The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19(1):41–47.
- Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Medical Journal of Australia. 2011;195(6):S65–S112.
- Boyle J, Teede HJ. Polycystic ovary syndrome: an update. Australian Family Physician. 2012;41(10):752–756.
- Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. Journal of Clinical Epidemiology. 1998;51(7):581–586.
- Piltonen TT, Koskenkari N, Koivuaho E, Morin-Papunen L, Hurskainen E, Gissler M, Arffman RK, Ollila MM. Increased mortality in polycystic ovary syndrome – a cohort study. European Journal of Endocrinology. 2026;194(5):724–731.


